Allergen buys Kythera Biopharmaceuticals for $2.1B
Allergan has completed the acquisition of Kythera Biopharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel…
Pharmaceuticals, Biotechnology and Life Sciences
Allergan has completed the acquisition of Kythera Biopharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel…
Allergan plc has announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market Juvederm ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
Allergan plc has updated its second-half 2015 continuing operations financial forecast. The forecast reflects adjustments for the upcoming expected discontinued operations
Allergan plc announced on Friday that it has launched a generic version of Janssen’s Invega (paliperidone extended-release tablets) in the…
Amgen and Allergan plc. announced on Wednesday that a Phase 3 study of biosimilar candidate ABP 215 met its primary…
Allergan, a Dublin-headquartered pharmaceutical company, confirmed on Monday that it has filed an Abbreviated New Drug Application (ANDA) with the…
Allergan has announced a nationwide partnership with the Caregiver Action Network (CAN), a family caregiver organization, to provide thank you meals to 1,000…
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…
Allergan and U.S. Women’s Health Alliance (USWHA), an organization focused on promoting high-quality, affordable healthcare for women, have announced an…